Combined device for rapidly and quantitatively detecting multiple tumor markers

Abstract

A combined device for rapidly and quantitatively detecting multiple tumor markers is characterized by being composed of 3 to 8 pieces of independent tumor marker test paper such as AFP, CEA, PSA, CA125, CA153, CA199, CA242 and NSE, a clamping shell special for the 3 to 8 pieces of test paper, and an immune layer result analysis and judgment recorder with built-in corresponding standard curves and the judgment method. The test paper can be combined to form the detection device with the 3 to 8 pieces of test paper according to the specific requirements. The standard curves and the judgment method for the 8 pieces of test paper are built in the immune layer result analysis and judgment recorder and used for conducting quantitative judgment on test results, and forecasting of various tumor occurrence conditions can be conducted on different types of combination of the test results through the judgment method. Detection is completed within 15 minutes to 20 minutes. The combined device for rapidly and quantitatively detecting the multiple tumor markers has the advantages of being combined in detection, easy and convenient to operate, rapid in response, accurate in result, suitable for on-site test and the like, and the requirements for more accurate, easier and move convenient clinical detection are met.

Description

technical field [0001] The patent of the present invention relates to the technical field of medical clinical diagnosis, in particular to a rapid quantitative combined detection device for various tumor markers prepared by an immunocolloidal gold rapid detection method. Background technique [0002] Certain substances produced and released by tumor cells often exist in tumor cells or in host body fluids in the form of metabolites such as antigens, enzymes, and hormones. Tumors can be identified or diagnosed based on their biochemical or immune characteristics. Tumor markers are mainly used clinically for the discovery of primary tumors, the screening of high-risk groups for tumors, the differential diagnosis of benign and malignant tumors, the judgment of tumor development, the observation and evaluation of tumor treatment effects, and the prediction of tumor recurrence and prognosis, etc. . [0003] Common tumor markers are: [0004] 1. Alpha-fetoprotein [0005] 1) Prim...

AI Technical Summary

Problems solved by technology

[0025] 3) Other non-malignant tumors also have different degrees of increase, but the positive rate is low: such as endometriosis, pelvic inflammatory disease, ovarian cyst, pancreatitis, hepatitis, liver cirrhosis, etc.

At present, there is no reagent that uses the colloidal gold method to quantitatively detect multiple indicators.

Images